Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism

Hypertension

Volumn 29, Issue 3, 1997, Pages 723-727

  Shigematsu, Yuji ^a,b   Hamada, Mareomi ^a   Okayama, Hideki ^a   Hara, Yuji ^a   Hayashi, Yutaka ^a   Kodama, Koji ^a   Kohara, Katsuhiko ^a   Hiwada, Kunio ^a  

^a Second Dept of Internal Medicine   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

hemodynamics; hyperaldosteronism; hypertension, essential; hypertrophy, left ventricular

Indexed keywords

ADULT; AGED; ARTICLE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEMODYNAMICS; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RETINOPATHY; TARGET ORGAN;

EID: 0031026657     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.29.3.723     Document Type: Article

References (39)

1. Orth DN, Kovacs WJ, DeBold CR. The adrenal cortex. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology. Philadelphia, Pa: WB Saunders Co; 1992;8:489-619.
2. Pearce P, Funder JW. High affinity aldosterone binding sites (type I receptors) in rat heart. Clin Exp Pharmacol Physiol. 1987;14: 859-866.
3. Barnett CA, Pritchett EL. Detection of corticosteroid type I binding sites in heart. Mol Cell Endocrinol. 1988;56:191-198.
4. Lombès M, Oblin M-E, Gasc J-M, Baulieu EE, Farman N, Bonvalet J-P. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res. 1992;71:503-510.
5. Frohlich ED, Tarazi RC. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol. 1979;44: 959-963.
6. Frohlich ED. Left ventricular hypertrophy, cardiac diseases and hypertension: recent experiences. J Am Coll Cardiol. 1989;14: 1587-1594.
7. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83:1849-1865.
8. Hall CE, Hall O. Hypertension and hypersalimentation, I: aldosterone hypertension. Lab Invest. 1965;14:285-294.
9. Duprez DA, Bauwens FR, De Buyzere ML, De Backer TL, Kaufman JM, Hoecke JV, Vermeulen A, Clement DL. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol. 1993;71:17A-20A.
10. Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K. Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension. J Hypertens. 1995;13:155-160.
11. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
12. Keith NM, Wagener HP, Barker MW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci. 1939; 197:332-343.
13. Dazai Y, Iwata T, Hiwada K. Augmentation of the renal tubular dopaminergic activity by oral calcium supplementation in patients with essential hypertension. Am J Hypertens. 1993;6:933-937.
14. Wu AHB, Gornet TG. Preparation of urine samples for lipid-chromatographic determination of catecholamines: bonded-phase phenylboronic acid, cation-exchange resin, and alumina adsorbents compared. Clin Chem. 1985;31:298-302.
15. Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K. Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy. Jpn Circ J. 1995;59:329-336.
16. Sahn DJ, DeMaria A, Kisslo J, Weyman A, The Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
17. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977;55:613-618.
18. Reichek N, Devereux RB. Reliable estimation of peak left ventricular systolic pressure by M-mode echocardiographic-determined end-diastolic relative wall thickness: identification of severe valvular aortic stenosis in adult patients. Am Heart J. 1982;103:202-209.
19. Ganau A, Devereux RB, Roman MJ, De Simone G, Pickering TG, Sabe PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550-1558.
20. Campbell SE, Diaz-Arias AA, Weber KT. Fibrosis of the human heart and systemic organs in adrenal adenoma. Blood Pressure. 1992; 1:149-156.
21. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res. 1990;67:1355-1364.
22. Young M, Fullerton M, Dilley R, Funder J. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest. 1994;93:2578-2583.
23. Robert V, Van Thiem N, Cheav SL, Mouas C, Swynghedauw B, Delcayre C. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension. 1994;24:30-36.
24. Robert V, Silvestre J-S, Charlemagne D, Sabri A, Trouve P, Wassef M, Swynghedauw B, Delcayre C. Biological determinants of aldosterone-induced cardiac fibrosis in rats. Hypertension. 1995;26(part 1):971-978.
25. Darrow D, Miller HC. The production of cardiac lesions by repeated injections of desoxycorticosterone acetate. J Clin Invest. 1942;21: 601-611.
26. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation. 1990;82: 1730-1736.
27. Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, Aristimuno GG. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med. 1980;93:817-821.
28. Kobrin I, Frohlich ED, Ventura HO, Messerli FH. Renal involvement follows cardiac enlargement in essential hypertension. Arch Intern Med. 1986;146:272-276.
29. Dimmitt SB, West JNW, Eames SM, Gibson JM, Gosling P, Littler WA. Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet. 1989;1:1103-1105.
30. Dahlöf B, Stenkula S, Hansson L. Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment. Blood Pressure. 1992;1:35-44.
31. De Leonardis V, Becucci A, De Scalzi M, Cinelli P. Low incidence of cardiac hypertrophy in essential hypertensives with no retinal changes. Int J Cardiol. 1992;35:95-99.
32. Devereux RB, Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation. 1993;88(part 1):1444-1455.
33. Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Stokes J III, Feinleib M, Castelli WP. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation. 1987;75(suppl I):I-26-I-33.
34. Tarazi RC, Ibrahim MM, Bravo EL, Dustan HP. Hemodynamic characteristics of primary aldosteronism. N Engl J Med. 1973;289: 1330-1335.
35. Suzuki T, Abe H, Nagata S, Saitoh F, Iwata S, Ashizawa A, Kuramochi M, Omae T. Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism. Am J Cardiol. 1988;62:1224-1227.
36. Ganau A, Devereux RB, Pickering TG, Roman MJ, Schnall PL, Santucci S, Spitzer MC, Laragh JH. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation. 1990;81:25-36.
37. Leenen FHH, Tsoporis J, Cardiac volume load as a determinant of the response of cardiac mass to antihypertensive therapy. Eur Heart J. 1990;11(suppl G):100-106.
38. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991; 114:345-352.
39. Dunn FG, Chandraratna P, de Carvalho JG, Basta LL, Frohlich ED. Pathophysiologic assessment of hypertensive heart disease with echocardiography. Am J Cardiol. 1977;39:789-795.